ad book 2013 combine staples (2)
DESCRIPTION
ÂTRANSCRIPT
A Very Special Thank you to Everyone People in Recovery, Families and Friends
Educating the Public about The Value of Prevention, Treatment & Recovery
Brochure Sponsored By: Spectrum Health Services
Massachusetts Organization for Addiction RecoveryMassachusetts Organization for Addiction Recovery
23rd Recovery Month Celebration Day23rd Recovery Month Celebration Day Thursday September 26, 2013Thursday September 26, 2013
MOAR Joins the Voices for Recovery in Celebrating
Together on Pathways to Wellness
Toll Free:
1 (877) 423-6627
www.moar-recovery.org
Page 1
In celebration of National Recovery Month, The Dimock Center salutes the Massachusetts Organization for Addiction Recovery (MOAR)
for their long-standing work in highlighting the Voices of Recovery!
The Dimock Center is the largest provider of substance abuse and mental health treatment services, including support for the developmentally disabled,
in Boston’s inner-city. With integrated care, Dimock is able to provide a holistic approach and offer a continuum of services to men, women, adolescents and families
living with children in Roxbury, Dorchester, Mattapan, Jamaica Plain, Roslindale, West Roxbury and the South End.
Some of our programs include:The Mary Eliza Mahoney House Family Shelter Acute Treatment Services Clinical
Stabilization Services (CSS) Outpatient Addiction & Recovery Services Adult Mental Health Services John Flowers Recovery Program My Sister’s House at Dimock Sheila
Daniels House and Edgewood House…and many more!
FOR ALL OF YOU
The Dimock Center | 55 Dimock Street | Roxbury, MA 02119617.442.8800 | www.dimock.org
Join our online community!
Page 2
Alkermes is a Proud Sponsor of MOAR and the
Massachusetts Recovery Month Celebration
For more information about Alkermes and its innovative medicinesdesigned to help people living with serious, chronic diseases,
including addiction disorders, please visit:
www.alkermes.com
Ads-8.5x11" bleed BW.indd 1 8/27/13 4:26 PM
Page 3
The United States Dept of Health and Human Services, Substance Abuse Mental Health Services Administration,
Center for Substance Abuse Treatment
Governor Deval Patrick Public Health Commissioner, Cheryl Bartlett
MA DPH Substance Abuse Services Director, Hilary Jacobs Bureau of Substance Abuse Services, Julia Ojeda The City of Boston, Mayor Thomas M. Menino
And his special staff, Michael Kineavy The Boston Public Health Commission, Barbara Ferrer and Rita Nieves
Some of the Public Policy Leaders Supportive of Recovery Month! Senate President Therese Murray, House Speaker Robert DeLeo,
Senate and House Chair Mental Health & Substance Abuse Committee: Senator Joan Lovely and Rep Elizabeth Malia, Senate House Ways and Means Chairs: Senator Stephen M Brewer
and Brian Dempsey, Public Health Committee Chairs: Senator John Keenan and Rep Jeffrey Sanchez, Rep. James O’Day, Rep. Marty Walsh, Rep. Alice Peisch, Senator Cynthia Creem, and MOAR!
Thank You to
Improbable Players, Joanne Peterson-Learn to Cope, Recovery High Schools, Woody Giessmann, Good Samaritan Campaign Members, Massachusetts Coalition for Addiction Services, Rick Dyer,
Deborah Delman-Transformation Center, & Faces and Voices of Recovery.
The MOAR Amazing, Extraordinary and Fantastic Brochure Sponsorship Highpoint Treatment Center, Spectrum Health Systems Inc, The Dimock Center, AdCare Hospital,
Phoenix Houses of NE, Massachusetts Behavioral Health Partnership, Foundation for Alcohol Education, North Suffolk Mental Health Association, Association for Behavioral Health, and Alkermes Inc.
Recovery Day Celebration Committees –Brian Greene, Tom Scott, John Frazier, Mark Muhammad, Maureen
Harvey, Amos Marshall, Linda Mazak, Joe Kelleher, Woody Giessmann, Rick Dyer and you! Motorcycle Ride Chairs: Stephanie Almeida, Rocco Antonelli Jr, and Frank Azzaritti.
Massachusetts Recovery Month Activities in Springfield, Boston, Worcester, Greenfield,
New Bedford, Quincy, and everywhere!
We can further celebrate the showing of The Anonymous People across Massachusetts!
MOAR of a Special Thank You For Making Our Addiction Recovery Celebration Events
September 2013 MOAR Possible
Page 4
The Massachusetts Department of Public Health
Bureau of Substance Abuse Services &
Their Staff and Provider Community
Wish to Warmly Congratulate
Massachusetts Organization for
Addiction Recovery
for their celebration marking
September 26, 2013
National Recovery Day
Cheryl Bartlett, Commissioner Massachusetts Department of Public Health
Hilary Jacobs, Director Bureau of Substance Abuse Services
Page 5
Substance Substance Substance
Abuse Abuse Abuse
is is is SufferingSufferingSuffering
North Suffolk offers
strength and
hope
Independence through intervention
Noddles Island Multi-Service Agency Locations:
14 Porter Street Conexions East Boston, MA 02108 (617) 912-7502 Meridian House 301 Broadway (617) 569-6050 Chelsea, MA 02150 To make an appt. 25 Staniford St call central intake Boston, MA 02114 1-888-294-7802
North Suffolks Supports MOAR and National Recovery Month
Page 6
Advocates supports individuals in recovery with a full continuum of behavioral health services.
• Outpatient Counseling and Psychiatry • Addiction Counseling• Treatment for Co-Occurring Disorders• Drug Court Programs• Psychiatric Emergency Services
We are proud to join MOAR in celebrating
National Recovery Month 2013
Locations in Waltham, Framingham, Marlborough, Acton, and Ayer.
Call us today at (508) 661-2020 or visit us online at www.AdvocatesInc.org.Page 7
www.moar-recovery.org
MOAR President, Amos Marshall invites you to support the September 2013 With The 23rd MOAR and Friends National Recovery Month Celebration Theme:
“Join the Voices for Recovery: Together on Pathways to Wellness!”
It is people in recovery, you and me, our families and friends, who are the voices, for recovery. My addiction took me to the streets; support from a shelter brought me to long-term treatment, and now I am the New England Shelter for Homeless Veteran’s Substance Abuse Service Director. I am a face and voice for addiction recovery. I am in long term recovery. It is our stories, who can invite communities to become involved in promoting treatment and recovery support services for the millions of Americans who are suffering from alcohol and other drug addiction. We know that only 20% of people who need treatment get it
People who need treatment further need recovery support services The Problem:
We know too well that 5529 people died from Opioid overdoses from 2002-2010 in Massachusetts. Many were from prescription drugs…..Now we know of Molly, (Ecstasy) Will Medical Marijuana really be for Medical Purposes?
Alcohol and other drug addictions prevail in HIV-AIDS, Hepatitis C, mental health symptoms, and other
physical diseases. We know too well that when young people start drinking before the age of 15, they are more susceptible to alcohol problems. Do you suppose that alcohol advertising has something to do with youth use?
Only 3% of the state budget that is burdened by the problems caused by substance use disorder is
spent on prevention, treatment and recovery. (Shoveling Up Study 2009- Columbia University)
80% of people in the prison system are there with alcohol and other drug related problems.
We know people in recovery often fear speaking up because of fear of being judged. They feel stigma.
MOAR is in The Solution – We are MOAR Visible
M MOAR learned that many people overdose and die because witnesses fear arrest because of illegal drug use. We learned this from the state’s 15 Mass Call 2 opiate overdose prevention coalitions. We helped facilitate a successful Good Samaritan Campaign to reduce the fear of getting arrested for illegal drug use. MOAR wants you to leave as a card carrying Good Samaritan member!
The new law protects both witnesses and overdose victims from being charged or prosecuted for possession of a controlled substance when calling 911 during an overdose. (Protection excludes a warrant or the presence of significant drug distribution.)
It provides legal protection for prescribing of Naloxone (Narcan) (opioid overdose reversal agent) and for those (such as family members) who possess and/or administer Naloxone to someone having an opioid overdose.
It will save lives by making it more likely that someone witnessing an overdose will call 911. We hope that The Good Samaritan Campaign will be instituted in The MOAPC- Massachusetts Opioid
Abuse Prevention Collaborative Program (MOAPC) in 71 communities. Will you help spread the word about The Good Samaritan Campaign
Page 8
MOAR as a Massachusetts Coalition for Addiction Services (MCAS) Member, educated policymakers about need for improved addiction services. The coalition, chaired by Connie Peters-Association for Behavioral Healthcare, with at least 10 other organizations educated policymakers with stories, facts and stats to improve state supported services with increased funding! MOAR helped educate policymakers about too many prescriptions leading to addiction and death. Senator John Keenan (Quincy) lead -- A Prescription Monitoring Law is in effect…as of 2012
Prescribers for controlled substances, such as opiates, to be registered in the Prescription Monitoring Program
Prescribers will utilize the program prior to seeing a new a patient. Client histories will be checked. Clients’ names will be confidential.
Pharmacists will learn how to use the Prescription Monitoring Program and it will be part of licensing requirements.
Pharmacists will check for prescription validity.
MOAR strongly believes in Senator’s Keenan’s proposal to make the Medical Marijuana law stricter. MOAR likes Senator Tarr’s move to make the Marijuana Decriminalization Law stricter.
MOAR as a SAFE - MA, Supporting an Alcohol Free Environment in Massachusetts Member helped with the leadership of Prevention coalitions and their youth members educate MBTA personnel to eliminate alcohol ads from the Boston area transit system. Why? Advertising lures young people into drinking before legal age, which factors into alcohol addiction. MOAR further supports improvement from insurance coverage. MOAR is spreading the word about Knowing Your Rights Regarding Insurance Parity Call Health Law Advocates. More Info call 617-338-5241. MOAR wants to make sure Parity is enforced in The National Affordable Care Act These men and women had earned “good time” to make this move happen. We would, MOAR participated in a statewide Behavioral Health Advisory Council which was to advise the state legislature about integrating addiction services with other health care services in Accountable Care Organizations, a team approach to healthcare.
MOAR is pleased that Accountable Care Organizations can include: Licensed Alcohol and Drug Clinicians (only licensed professional with requirement for
addiction experience, knowledge, and skills) Recovery Coaches and Peer Navigators to help individuals and families to become
familiar with supportive services. MOAR has 2 peer Recovery Coaches via the state’s Access To Recovery Program.
MOAR served as a Bringing Recovery Supports Services to Scale (BRSS- TACS) Committee member. The project serves to enhance the role of peer services and recovery coaches in health care services as part of a process to help the voices of people in recovery count throughout services. Next BRSS-TACS measure, RAH, Recovery Access to Health Care , a partnership with Transformation Center, to provide recovery communities opportunities to become educated about health care plans and choices. MOAR wants you to know that One Care is available in October for people on Medicaid and Medicare! MOAR applauds efforts to make sober housing ‘sober’ – will you help! MOAR supports EPOCA and FAMM with any and all moves to reinforce rehab vs. recidivism! MOAR is pleased to be allied with many prevention coalitions and family support groups. MOAR is pleased to have a voice with Faces & Voices of Recovery and Addiction Recovery Community Organizations! In fact – Maryanne Frangules is the Faces and Voices of Recovery New England Representative.
Go to www.moar-recovery.org. Call 617-423-6627! Page 9
~ Congratulations MOAR ~
For your leadership in promoting prevention, treatment and Recovery
Keep up the great work!
From your friends at the
Association for Behavioral Healthcare
www.ABHmass.org
Page 10
Join the Voices for Recovery!
Let us make “Join The Voices for Recovery: Together on Pathways to Wellness”
The National Recovery Month 2013 theme,
An everyday way of life!
MOAR BOARD President: Amos Marshall, Vice President: Tom Delaney, Clerk: Rocco Antonelli Jr., Treasurer: Joe Kelleher, Exec. Director:
Maryanne Frangules Board Members: James Direda, Rick Dyer, Woody Giessmann, Maureen Harvey, Paul Kusiak, Kate McHugh,
Daniel O’Connor, Rob Pezzella, and Vicente Sanabria MOAR Staff: Tom Scott, Patrick Cronin, John Frazier, and Mellisa Prefontaine.
MOAR is a non-profit organization with Third Sector New England as our fiscal sponsor.
MOAR Mission
To organize recovering individuals, families and friends into a collective voice
to educate the public about the value of recovery from alcohol and other
addictions.
MOAR Vision
To live in a society where addiction is treated as a significant public health
issue and recovery is recognized as valuable to our communities.
MOAR Mission
To organize recovering individuals, families and friends into a collective voice
to educate the public about the value of recovery from alcohol and other
addictions.
MOAR Vision
To live in a society where addiction is treated as a significant public health
issue and recovery is recognized as valuable to our communities.
Page 11
Page 12
Alcohol and Drug Addiction Recovery Services
Massachusetts Substance abuse Information and Education Helpline
Director: Robin Fox 1-800-327-5050
www.helpline-online.com
Association for Behavioral Healthcare
President, CEO: Vic DiGravio 508-647-8385
www.mhsacm.org
American Society of Addiction Medicine
MD, Chair: Daniel McCullough 978-927-1859
www.asam.org
EAPA MA/RI Employee Assistance Professionals Association
President: Daniel O’Connor 617-364-8628
www.mari-eapa.org
Institute for Health and Recovery
Norma Finkelstein 617-661-3991
www.healthrecovery.org
Community Associations Serving Alcoholics- CASA
Joseph Kelleher 617-971-9360
MA Association of Sober Housing
Marilyn DiOrio 781-838-0463
Lawyers Concerned For Lawyers
Gina Walcott 617-482-9600
MA Association of Alcoholism and Drug Abuse Counselors
President: Sue O’Connor 413-323-9544
www.maasac-ma.org
MA Board of Substance Abuse Counselor Certification-MBSACC
Jacquelyn Cummings 508-842-8707
www.mbsacc.org
MA Council on Compulsive Gambling
Executive Director: Kathleen Scanlon 800-426-6447
www.masscompulsivegamling.org
MA Housing and Shelter Alliance
President: Joseph Finn 617-367-6447
www.mhsa.net
Page 13
Boston Public Health Commission
Rita Nieves 617-534-5395
www.bphc.org
New England Alliance for Addiction Recovery
Director: Patty McCarthy 802-229-6103
www.neaar.org
Recovery Homes Collaborative
President: Robert Monahan 617-773-7023
www.Recoveryhomescollaborative.com
MA Black Alcoholism & Addiction Council
Leah Randolph 617-903-8176
Project ABLE
Director: Mary Ann Hart 617-864-0606
www.projectablema.org
Parent Support Group of Western MA
Barbara Gallo 413-246-0677
The Parents Forum
Eve Sullivan 617-253-7182
Whatever It Takes Parent Support Group
Deb Sadowy 413-442-0935
Learn To Cope
Joanne Peterson 508-801-3247
www.learn2cope.org
Faces and Voices of Recovery
New England Representative: Maryanne Frangules 617-423-6627
www.facesandvoicesofrecovery.org
The National Center on Addiction and Substance Abuse-CASA
Columbia University 212-841-5200
www.casacolumbia.org
Labor Assistance Professionals
Dan Ryan 617-328-0096
www.laborassistanceprofessional.com
Join Together 617-437-1500
www.jointogether.org
Page 14
Allston-Brighton Substance
Abuse Task Force
Celebrates National Recovery
Month With MOAR Every Day!
Our Mission The Allston-Brighton Substance Abuse Task Force is a coa-
lition of community agencies and residents that mobilizes youth, fami-
lies, community members and leaders to prevent and reduce sub-
stance abuse among youth and adults in our community.
We aim to:
- Educate youth, families, community leaders and members
- Raise awareness about substance abuse prevention and treatment
- Provide resources and support to families and community members
- Change community norms around substance abuse
www.abdrugfree.org
Page 15
A PUBLIC POLICYMAKER TELEPHONE ACCESS GUIDE
Governor: Deval Patrick 617-727-3600
Department of Public Health Commissioner: 617-624-5200
Cheryl Bartlett
Department of Public Health Director of 617-624-5151
Bureau of Substance Abuse Services: Hilary Jacobs
Department of Public Health, Constituent Liaison, 617-624-5147
Bureau of Substance Abuse Services: Julia Ojeda
Senate President: Therese Murray 617-722-1500
Senate Ways and Means Chair:
Senator Stephen M. Brewer 617-722-1540
Senate Minority Leader: Senator Bruce E. Tarr 617-722-1600
Senate Clerk’s Office: 617-722-1276
Senate Lobby : 617-722-1455
House Speaker: Representative Robert A. DeLeo 617-722-2500
House Ways and Means Chairman:
Representative Brian S. Dempsey 617-722-2990
House Minority Leader:
Representative Bradley H. Jones, Jr. 617-722-2100
House Clerk’s Office: 617-722-2356
House Lobby: 617-722-2000
Mental Health Substance Abuse Committee Co-Chairs:
Senator Joan Lovely 617-722-1410
Representative Elizabeth A. Malia 617-722-2060
Mental Health Substance Abuse Committee Vice-Chairs:
Senator Katherine Clark 617-722-1206
Representative Angelo Scaccia 617-722-2060
State's Citizen Information Number: 800-392-6090
To Find Your legislator’s Name and More Go on The Web:
www.wheredoivotema.com
For all State Legislative Information go online to www.mass.gov/legis/
The State House Main Number 617-722-2000
Page 16
In Memory of
Casey C. Washburn
Born in Boston, Massachusetts on Jun. 26, 1984 Died Jul. 24, 2008
Casey C. Washburn, died too soon at 24 years old from a drug overdose. His parents, Ken and Kerry, as other family and friends, will
remember his quick wit, big heart, and sense of humor. They knew him as kind and hopeful to the very end.
As a testimony to Ken and Kerry, and too many other families, MOAR honors Casey’s memory and that of others, who have died from an over-dose. MOAR will continue to collaborate with all to move to save lives,
and keep the hope of recovery alive.
Page 17
Online at: Find us on Facebook: Follow us on Twitter:
www.casaesperanza.org facebook.com/CasaEsperanzaInc twitter.com/CasaEsperanzaMA
Page 18
Remembering Our Friends Who Have Passed Away,
Who Helped So Many People To Build a Life in Recovery
All “Visible, Vocal, Valuable”
Bob Herne
A Friend to The Recovery Community
The New England Ride for Recovery August 24, 2013 was dedicated to Bob Herne
Remembering Lives Cut Short by Drug Overdoses
Learn to Cope Parent Support Group with Banner Remembering Lives Lost Rallying for a Time When Such Deaths are No More
Page 19
Certificate Program
Supports
RECOVERY MONTH
Join the Voices of Recovery-
Together on Pathways to Wellness
ADDICTION COUNSELOR EDUCATION
In Worcester…
The Addiction Counselor Education (ACE) program offers a one-year Certificate program with
classes one night a week to help prepare for a career in Addiction Counseling and
Certification/Licensure in Massachusetts.
For More Information Call (508) 752-7313
www.ace-adcare.org
Page 20
COASA: CHILDREN OF ALCOHOLISM AND SUBSTANCE ABUSE
One in four children in the United States lives with substance abuse in the family.
There are over 142,000 children in Boston and up to 47,000 of them are directly affected by alcohol and/or other substance abuse. Experience tells us that these children are at great risk of developing serious emotional, physical, relational, learning, psychological and spiritual problems. They are more likely to have difficulty relating to peers, become victims of neglect and abuse, and are at the highest risk of either becoming substance abusers themselves or of becoming involved in
not-for-profit child-welfare organization based in Boston, is initiating advocacy and developing resources for the children of alcoholics and other substance abusers of Boston through a program called COASA, Children of Alcoholism and Substance Abuse, the local affiliate of NACOA, the National Association for Children of Alcoholics.
COASA supports children of alcoholism and substance abuse by serving as an advocate for them in community forums and by developing appropriate supportive educational groups for them in Boston. COASA facilitates school and community-based prevention/intervention services, adapting them for the particular needs of the children we serve. The program provides the children with a framework for understanding what they are experiencing and teaches them to break the
an take CARE of themselves, can COMMUNICATE their feelings, can make healthy CHOICES and can CELEBRATE being themselves). The purpose of the program is to provide ongoing validation, support in developing positive social skills and improvement of individual self-esteem.
COASA works within the Boston neighborhoods with the drug coalitions now in place and
with the Massachusetts Organization for Addiction Recovery (MOAR). The program offers resources to the children, whether parents or other family members are in treatment or not.
For more information contact:
COASA, c/o Maureen McGlame Rob
Corps11 Beacon Street Boston, MA 02108
TEL: (617) 227-4183FAX: (617) 227-2069 www.rfkchildren.org
Page 21
Comics For Recovery Supports MOAR & National Recovery
Month
THIS IS YOUR BRAIN NOT ON DRUGS
Page 22
Physician Health Services, Inc. A Massachusetts Medical Society Corporation
860 Winter Street, Waltham, MA 02451
www.physicianhealth.org
Steven A. Adelman, M.D. Telephone: (800) 322-2303, ext. 7404
Director (781) 434-7404
Mission Statement Physician Health Services, Inc. (PHS) is dedicated to improving the health, well-being, and
effectiveness of physicians and medical students while promoting patient safety. This is achieved by
supporting physicians through education and prevention, as well as assessment, referral to
treatment, and monitoring.
PHS provides assistance with a wide variety of personal and professional situations. Any one of the following
issues may represent a reason to refer someone to PHS or contact us:
Difficulty balancing work and family
Difficulty managing stress, burnout, or financial
pressure
Difficulty managing a practice or coping with a
competitive work environment
Difficulty managing administrative burdens
Challenges with retirement planning or a
career change
Distressed or disruptive behavior
Anxiety, depression and mood disorders
Acute and/or post-traumatic stress
Malpractice stress
Stress following an unexpected outcome or medical
Error
Medically induced trauma
Alcohol and substance use concerns
Interpersonal problems
Concerns about loss of memory and age-related
challenges
Attention issues
Learning disabilities
Sleep disorders
Eating disorders
Medical problems
Professional boundary issues
Domestic violence
Marital problems
Compulsive Gambling
Physician Health Services Provides: Referral to treatment and counseling
Recovery monitoring and documentation
Support groups for physicians, medical students, and their families
Networking opportunities with colleagues experiencing similar issues
Educational programs and presentations at medical institutions
Guidance to hospitals and health care organizations regarding how to handle matters of physician health
Grand rounds, lectures, and speeches at committee and specialty society meetings
Physician Health Services is a nonprofit corporation of the Massachusetts Medical Society, that provides a
safe, confidential environment designed to help identify, refer to treatment, guide, and monitor the recovery
of physicians and medical students with health concerns.
Help is available and it works.
Educational Opportunities
Caring for the Caregivers IX: How Do We Reduce Physician Stress and Burnout
October 3, 2013 - Massachusetts Medical Society Headquarters, Waltham, MA
Managing Workplace Conflict: Improving Personal Effectiveness
October 17 & 18, 2013 - Massachusetts Medical Society Headquarters, Waltham, MA
To register or for more information please call 800-843-6356 or visit
http://www.massmed.org/Continuing-Education-and-Events
Page 23
Page 24
MA Black Alcoholism & Addictions Council
Supports National Recovery Month 2013
Joining the Voices for Recovery-
Together on Pathways to Wellness!
Congratulations to 23 years!
895 Blue Hill Avenue
Dorchester, MA 02124
Call: 617.506.8188
www.cmhwc.com
Thank you Maryanne and
MOAR
We proudly support
National Recovery Month
Together on Pathways to Wellness
Congratulations
-David & Leah
Page 25
The Transformation Center is a peer-operated center that is spinning off from M-POWER to strengthen a mental health focus on wellness and life recovery through dialogue, education, systems change advocacy, and peer support. We currently offer training for Peer Specialist Certification, Leadership Academy, WRAP Facilitation, Recovery Conversations for Providers and more. The Transformation Center works closely with the six (6) Recovery Learning Com-munities (RLCs) across the state. RLCs offer training and support for peers working and volunteering to promote wellness and recovery in the local communities.
The Transformation Center 98 Magazine St Roxbury, MA 02119 Telephone: (617) 442-4111 Toll-free: (877) 769-7693 TTY: (617) 442-9042 Fax: (617) 442-4005 [email protected]
Supports National Recovery Month 2013
Joining the Voices for Recovery-
Together on Pathways to Wellness!
Page 26
PPiinnee SSttrreeeett IInnnn ssuuppppoorrttss MMOOAARR
aanndd NNaattiioonnaall RReeccoovveerryy MMoonntthh 22001133 ““JJooiinniinngg tthhee VVooiicceess ffoorr RReeccoovveerryy
TTooggeetthheerr oonn PPaatthhwwaayyss ttoo WWeellllnneessss!!””
444 Harrison Avenue
Boston, MA 02118
617-892-9100
www.pinestreetinn.org
Page 27
Board Members President
Joe Kelleher
Gavin Foundation
857-496-0052 x803
Vice President
Greg Arsenault
617-285-2607
Treasurer
James Killarkey
Hello House
617-262-7142
Sharon Day
Barnstable Sherriff’s Office
508-563-4435
John Dolan
Suffolk County Sherriff’s
Department
617-635-1000
John Frazier
617-527-0237
Rita Graham
Boston Medical Center
617-638-7217
Ray Hoitt
781-878-1291
Paul Johnson
Addiction Treatment Center
617-254-1271
Donna White
Shattuck Hospital
617-522-8110 x3343
C.A.S.A. Supports M.O.A.R.’s
Alcohol & Drug Addiction
Recovery Day
We would like to invite everyone
to attend CASA’s 46th
Annual
Alcoholism Information Day
Date: Friday June 6, 2014
Location: Florian Hall
55 Hallet Street, Dorchester
CEU’s for paid attendees
Registration for CASA Info Day $75
Page 28
Supporting National Recovery Month
with MOAR
Massachusetts Organization for Addiction Recovery
Page 29
Congratulations to MOAR for another successful year!!!
Behavioral Health Network
Is proud to
Join the Voices for Recovery-
Together on Pathways to Wellness!
BHN helps individuals, families, and communities improve the quality of lives for those with behavioral and
developmental challenges.
www.bhninc.org Page 30
7th ANNUAL REVERE BEACH MEMORIAL Sunday, September 29th at 7 PM William G. Reinstein Bandstand,
Revere Beach
Individuals who would like to remember a
loved one at the Memorial are invited to call (781) 485-6404 to register their loved ones’
names. Visit our website for details. www.reverecares.org
@Reverecarescoaltion
@RevereCARES
Committed to helping people live healthier and more productive lives
Driver Alcohol Education (DAE)
Multiple Offender Program (MOP)
Outpatient problem gambling assessment and treatment
Individual substance abuse and anger management counseling
Mental Health Clinic
Information/referrals for Family Members
29 Winter Street, 2nd
Floor
(Downtown Crossing)
Boston, MA 02108
617-482-5292
www.bostonasap.org
Joe Kelleher Business Manager
Gavin Foundation
70 Devine Way
South Boston, MA 02127
Tel: (857) 496-0052 ext. 803
Fax: (857) 496-0266
Page 31
1-800-327-5050 Need Help?
Call us to find it
Call the Helpline to find substance abuse
programs, hotlines, support groups, self-help
meetings, counseling services and community
resources.
www.helpline-online.com
The Massachusetts Substance Abuse Information and Education Helpline provides free and confidential information and referrals for alcohol and other drug abuse problems and related concerns. The Helpline is committed to linking consumers with comprehensive, accurate, and current information about treatment and prevention services throughout Massachusetts. Services are available Monday through Friday from 8:00 am to 11:00 pm and on Saturday and Sunday from 9:00 am to 5:00 pm. Language interpreters are always available. Follow us on Facebook and Twitter.
Funded by the Massachusetts Department of Public Health A project of Health Resources in Action
Health Resources in Action (HRiA) supports
Massachusetts Organization for Addiction Recovery
(MOAR) in their efforts to organize recovering
individuals, families and friends
into a collective voice to educate
the public about the value of recovery from
alcohol and other addictions.
Page 32
Groups.indd 1 6/26/2013 10:21:33 AM
IHR Administrative Headquarters349 BroadwayCambridge, MA 02139
www.healthrecovery.org
IHR provides family-centered, trauma-informed behavioral health treatment statewide — at client homes, community locations, and our offices.
Tel: 617-661-3991Fax: 617-661-7277TTY: 617-661-9051Toll free: 1-866-705-2807
METRO BOSTON95 Berkeley St.Boston, MA 02116
349 BroadwayCambridge, MA 02139
Choice NeighborhoodsMAC409 Blue Hill Ave.Roxbury, MA 02121
NORTHEaSTProject HEAL & Substance Abuse Engagement Project97 Central St.Lowell, MA 01852
SOuTHEaSTBRIGHT II & Family Recovery Project275 Martine St.Fall River, MA 02723
Ladder ProjectHigh Point30 Meadowbrook Rd.Brockton, MA 02301
RENEWAdcare Criminal Justice Services4 Court St.Taunton, MA 02780
WESTERN MaSS.Family Recovery Project225 High St.Holyoke, MA 01040
Access to Recovery The Johnson Life Center736 State St.Springfield, MA 01109
Some other IHR services are:
■ Centralized access to residential treatment and community housing for families and adolescents
■ Trauma integration training, technical assistance, and on-site clinical services
■ HIV prevention and education
■ Tobacco education and cessation programs
■ Treatment and case management for previously incarcerated individuals
■ Parenting and child development services
Page 33
Page 33
Peer to Peer Recovery Support Services are, as the word peer implies, both
designed and delivered by people that have experienced both addiction
and recovery. What is a Peer to Peer Facilitator?
Peer Facilitators are individuals in recovery that share their experiences, and are open to learning, and have a desire to help others along the path to recovery.
Peer Facilitators can be the individual that motivates a person new to recovery to move from the culture of addiction towards engagement in the culture of recovery.
Peer Facilitators provide support, set examples, guide and create an atmosphere conducive to learning for individuals seeking recovery.
MOAR Peer Facilitators: AREAS Supervisor- John R. Frazier East Boston- Mark F. Muhammad East Boston- Richard Sargent New Bedford- John Fortes III Springfield– Barbara Gallo Allston/Brighton– Cathy Connell
Interested in Peer to Peer Services?
Attend a MOAR AREAS group– call MOAR for info
Currently MOAR has weekly, one–hour peer to peer groups.
MOAR conducts practical problem solving groups for
people in recovery designed to strengthen their
participation in recovery and prevent relapse, by providing
information about common practical problems faced by
people in recovery and helping people connect to the
appropriate resource.
AREAS are peer lead, and the curriculum choices are driven
by the participating members. AREAS Participants receive
support and leadership development.
The AREAS Experience provides opportunities to become
involved with MOAR in a personal and meaningful way.
CONTACT:
Mellisa Prefontaine (617 423-6627)
Addiction Recovery Education Access Services
A Peer to Peer Recovery Support Service
Page 34
The Faulkner Hospital Addiction Recovery Program
Is Proud to Support National Recovery Day 2013
We are honored to Join the Voices for Recovery Together on Pathways to Wellness!
The Faulkner Hospital Addiction Program offers a comprehensive array of clinical services for individuals seeking recovery from alcohol and other drug addiction. We believe addiction is a treatable disorder, and that care provided by compassion-ate professionals in an environment of support and mutual respect heightens pa-tients’ self esteem and promotes medical, emotional, spiritual and social recovery. Evaluation and Consultation Individual Outpatient Counseling Group Counseling Dual Diagnosis Day Treatment Program Employee Assistance Faulkner Hospital 1153 Centre Street Boston, MA 02130
Family Counseling Ambulatory Detoxification Impatient Detoxification Program Evening Treatment Program
Addiction Recovery Inpatient Services (617) 983-7711 Outpatient Services (617) 983-7908
Page 35
The Good Samaritan Law
builds a path for hope and action
for anyone witnessing or experi-
encing an opioid overdose.
Everyone who is suffering from
opioid addiction, family
members, communities, schools,
law enforcement, and medical
professionals is included!
Background
An overdose is a medical emer-
gency. It requires an immediate
call to 911. Fearing arrest for
illegal drug use causes witnesses
not to call 911.
How It Works
The Good Samaritan Law provides
legal action for all to call 911 with
hope that a life can be saved!
( Yes- Law enforcement can still
secure the scene of an overdose,
and arrest for heavy drug trafficking
or outstanding warrants)
Narcan (Naloxone) Prescription
The law helps spread the word
about Naloxone (Narcan), a
medication that can reverse opioid
overdoses.
(Yes, The Massachusetts
Department of Public
Health has provided grants
for Narcan distribution)
Now— medical professionals
may prescribe Narcan to a
family member or
acquaintance of someone
suffering from opioid addic-
tion. In the event of an over-
dose, both the person who
administers the Narcan and
the prescribing professional
have legal protection.
Page 2 News
Thank You to Good Samaritan Members
Melissa Weiksnar (mother/author), Susan and Larry Sheehan (parents/Good Sam movers), Louellyn Lambros (concerned citizen), Katy Sugarman (Revere Cares
Coalition) Gary Langis (MassTAP), Rebecca Bishop, Lisa Conley, Berto
Sanchez, Sarah Mackin (all of Boston Pub-lic Health Commission), Emily Camin (Northeastern University Law Student)
and Lisa Whynott(Tapestry),
Over 19,000 persons were
trained to prevent, recognize and respond to an opioid overdose and administer naloxone (Narcan®). At this time, DPH has documented reversal of
over 2000 potentially fatal overdoses.
Law Enforcement Good Samaritan Activities:
Good Samaritan Fact Sheet included in law enforcement updates
Chief William Brooks, (Norwood ) and Chief Terrence Cunningham (Wellesley)
met to explore further improved Good Samaritan awareness
Quincy Police Department supported by Lt Detective Patrick Glynn used Narcan to
reverse more than 170 overdoses. Quincy Police are Good Samaritan educated!
School and Community Good Samaritan Steps:
Notice to school districts to inform students about Good Samaritan law
Health Education Bill in state legislature to include alcohol and drug prevention
• 15 state funded Opioid Overdose Prevention Coalitions provided support
71 MA communities will receive support to reduce opioid abuse and misuse
Weymouth, Saugus, and Revere Fire Departments now carry Narcan
Learn to Cope Parent Group Training Families to use Narcan
Healthcare Professionals Take Good Samaritan Action
Boston Medical Center’s Dr. Alex Walley leads the Narcan Project
Boston Medical Center Colleen Labelle, RN, educating nurses
Website http://prescribetoprevent.org on Narcan created
Join The Good Samaritan Campaign to
Spread the Word
Opioid Overdoses Kill 2 People a Day Hear This !
The Good Samaritan Law provides protection from drug
possession arrest when calling 911. Be a Good Samaritan!
Not calling 911 is # 1 reason overdose victims die!
Thank you to
Sarah Ruiz
& Thera Meehan
for DPH support
Interested? email [email protected]
Good Samaritan Campaign Action for Awareness More to Come—Join Us!
Page 36
Foundation for
Alcohol
Education
The Foundation supports small grant requests
that encourage, promote and impart by
education, knowledge of the effects of alcoholic
beverages in adolescence, and encourages drug
and alcohol abstinence.
Contact: Foundation for Alcohol Education, Inc. c/o Stephen A. Walsh
17 Hedding Avenue, South Hamilton, MA 01982-1732 Email: [email protected]
Page 37
Professional Referents:
We are committed to provide quality treatment for your patients and will work closely with you to define a collaborative treatment approach. Such collaboration ensures a seamless transition when the patient returns to your care. Referring therapists, physicians, addiction specialists, EAP’s, and interventionists may contact our Clinical Outreach Director who will help with questions and facilitate admission.
Contact: Lori McCarthy, LADC, CAIClinical Outreach Director
Phone: 781-366-0143 or E-mail: [email protected]
I N T E R V E N T I O N | T R E A T M E N T | R E C O V E R Y
New England’s Addiction Healthcare Provider
800-444-1554 │ www.gosnold.org
Medical Detoxification
Inpatient Rehabilitation
Extended Inpatient Care
Sober Living on Cape Cod
Intensive Outpatient Programs
Medication Assisted Treatment
Outpatient Addiction & Mental Health Services
Family Support & Education
Recovery Coaching
Intervention
Alumni Services
GOSNOLD PROUDLY SUPPORTS MOAR 2013 NATIONAL RECOVERY MONTH EVENTS
Page 38
Mission Edwina Martin house (EMH) is a 21-bed, residential addiction rehabilitation program exclusively for women. The organization aims to enable all residents to return to society with renewed self-esteem, sober and/or addiction-free, to reconnect with the community and family and be economically self-sustaining.
Edwina Martin House supports MOAR &
National Recovery Month
Proudly joining the Voices for Recovery
Together on Pathways to Wellness
www.edwinamartinhouse.org
Trudy and Richard Avery
Join the Voices
for Recovery and
MOAR in Celebrating
National
Recovery Month 2013
Page 39
“Recovery as a way of Life”
GRANADA HOUSE, INC.GRANADA HOUSE, INC.
www.granadahouse.org
Page 40
Prevention Works
Treatment is Effective
People Recover
98 North Front Street, 3rd floor
New Bedford, MA 02740
508-997-0475
www.hptc.org
Page 41
“Join the Voices for Recovery:
Together on
Pathways to Wellness”
98 North Front Street, 3rd floor
New Bedford, MA 02740
508-997-0475
www.southeastnetwork.org
Page 42
putting a grateful face on recovery with programs that dramatize the impact of substance abuse
and the reality of long-term recovery
join us! become a recovery advocate using your talents
in theater, comedy, writing, music
Contact the players: 617-926-8124 [email protected]
www.improbableplayers.org
improbable
f
I can honestly say I remember seeing the program in high school, feeling the way I felt and thinking, “Oh, wow! These people don’t drink and they’re happy. Maybe I can have a life after all.”
New England Center
Dedicated to quality training and
technical assistance services:
Prevention, Community awareness,
curriculum development, peer education,
stress management, and problem gambling prevention
We Support Recovery Month Every Day.
Page 43
Good Luck to MOAR
Massachusetts Organization for Addiction Recovery On its
23rd Annual Recovery Day Join the Voices for Recovery-Together on Pathways to Wellness!
Thank you for your continuing advocacy and support.
Hope & Recovery The Hope & Recovery Steering Committee of South Boston
To free the South Boston community from the abuse of harmful substances and promote healthy lifestyles.
Allston Brighton
Substance Abuse Task Force
Walk for Recovery
Hope you have a great day on Saturday, September 21st
At Herter Park, Brighton
Especially to Helen, Deidre, Sonia, Tim, Deb
“Advocacy for the value of addiction recovery is a capital
investment to our communities.”
Page 44
MBSACC
Massachusetts Board of Substance Abuse Counselor Certification
Certification is the process by which a non-governmental agency or association grants recognition to an individual who has met certain predetermined standards specified by that agency or association. It is designed to promote and maintain integrity and quality in a particular field. MBSACC is the organization charged with this responsibility as it pertains to the field of substance abuse in the Commonwealth of Massachusetts. It has faithfully, honestly, and professionally discharged this duty since 1981, without interruption. [email protected] PO Box 7070 Worcester MA 01605, 508-842-8707
Page 45
Page 46
Congratulations
Maryanne and MOAR
Education: Awareness
Recovery in Action
Ruth and Ray Kelley
Renee Kelley & David Nicholson
Homemade Ice Cream & Yogurt
Ice Cream Cakes, Pies, and Pizzas
Est.1976
www.theicecreamsmith.com
2295 Dorchester Avenue
Dorchester Lower Mills, MA 02124
617-296-8567
Come to the little ice cream parlor with the delicious old-fashioned
homemade ice cream. We make all our own ice cream right on the
premises, using the finest and freshest ingredients.
Page 47
visit us at www.hopehouseboston.org
Thank You MOAR for Recovery Day !
hope house
Page 48
The Membership of LAP
The Labor Assistance Professionals
Celebrate MOAR and Recovery Day
Membership from Unions Representing:
Boston Firefighters
Carmen’s Union
Teamsters
Musicians
IBEW– Telephone Workers and Electricians
Professional Firefighters from Massachusetts
City of Boston Workers
Machinists for Local 600
NERCC– New England Regional Carpenters Council
AFSCME- American Federation State County Municipal
Employees
County Correction Officers
Page 49
16
Lemuel Shattuck Hospital170 Morton Street
Jamaica Plain, Massachusetts 02130 617-522-8110
Recognizing MOAR and Celebrating Recovery Day in MassachusettsLemuel Shattuck Hospital Addiction Services
“Promoting Recovery at All Levels of Health Care” Hugh D. McCray, LADC-II, Jennifer C.Malizia, LMHC, CADAC
Marc B.Bell, CADAC , Donna White, RN, PHD, CS, CADAC-II
Lemuel Shattuck Hospital is a carefully structured network of services designed to treat the com-plex and intricate physical, emotional, and social needs of individuals. We take pride in being able to assist people with difficult medical and complex life situations in their recovery from addiction.
Lemuel Shattuck Hospital is a Massachusetts Department of Public Health Hospital, affiliated with Tufts University School of Medicine, Harvard Medical School, and the University of Massa-chusetts Medical School. The hospital operates 278 inpatient beds for adults 18 years of age and
over, as well as a continuum of psycho-social support services.
Contact Information: Addiction Services atLemuel Shsttuck Hospital, 617-971-3343
Cost of this promotion has bee privately funded.
Page 50
Thank you to Thank you to Thank you to MOAR for all MOAR for all MOAR for all the the the greatgreatgreat work work work you do and for you do and for you do and for creating a creating a creating a
community where community where community where together we all can together we all can together we all can “Join the voices of “Join the voices of “Join the voices of recovery on the recovery on the recovery on the pathway to wellness”!pathway to wellness”!pathway to wellness”!
-Representative Liz Malia Representative Liz Malia Representative Liz Malia
Page 51
Page 52
Page 53
Lowell House is a strong voice for recovery and wellness
in the Greater Lowell Area.
We’re proud to celebrate recovery month with our
friends and colleagues at MOAR and look forward to the
next 23 years of growth and success.
www.lowellhouseinc.com
St. Benedict Interfaith Christian Fellowship A Ministry of The Reformed Catholic Church International
“Serves All People”
Rev. Michael J. Scarlett, OCB 397 Robinson Street
Raynham, MA 02767
Ph. 508.944.3142.
www.revmichael.org
ONE GOD - Many Names / ONE SON - Many Paths /
ONE TRUTH - Many Faiths
Page 54
MAADAC is the Massachusetts Affiliate of NAADAC, the National
Association of Alcoholism & Drug Abuse Counselors
MAADAC Joins the Faces & Voices for Recovery
and MOAR to Celebrate Recovery Day 2013
Together on Pathways to Wellness
MAADAC’s Vision is to inspire Alcoholism & Drug Abuse Counselors
to create healthier families and communities through prevention,
intervention and quality treatment
MAADAC
www.maadac-ma.org MAADAC President: Sue O’Connor
Page 55
The Substance Abuse programs of
Bay Cove Human Services
Bay CoveHuman Services, Inc.66 Canal StreetBoston, MA 02114
wish to join
MOAR(Massachusetts Organization for Addiction Recovery)
in celebrating
September National Recovery Month.
Chelsea ASAP (617) 884-6829Bay Cove Treatment Center (617) 371-3030Andrew House (617) 479-9320New Hope (617) 878-2550Charlestown Recovery House (617) 242-0088
Page 56
Congratulations to the leadership of Maryanne Frangules
and the outstanding staff at MOAR
for your determination, vision and advocacy.
MOAR’s dynamic support of community-based substance
addiction services keeps treatment in Massachusetts
progressive, evidence-based and of the highest quality.
Victory Programs opens doors to recovery, hope
and community to individuals and families facing
homelessness, addiction or other chronic illnesses.
Victory Programs, Inc.
965 Massachusetts Avenue Boston, MA 02118
617.541.0222 www.vpi.org
Page 57
*
Middlesex Recovery PC
53 Cummings Park
Woburn MA 01801
(781) 305-3300
supports
National Recovery Month and
MOAR Everyday!
Joining the Voices for Recovery
Together
on Pathways to Wellness
Page 58
RReeccoovveerryy HHoommeess CCoollllaabboorraattiivvee ooff MMaassssaacchhuusseettttss
SSaalluutteess MMOOAARR aanndd aallll tthhee mmeenn aanndd wwoommeenn iinn rreeccoovveerryy!!
The Recovery Homes Collaborative is a group of long- term Residential Treatment programs whose purpose is to provide an association for the joint mutual effort of individuals and
groups, the mission of which is:
The rehabilitation of alcohol and /or drug addicted individuals through treatment in a Recovery Home setting.
The education of Staff and the community as to the problems and the process of the rehabilitation of the alcoholic/ addicts.
The healthy integration back into work, community, and family of such alcoholics/addicts.
Special thanks to all our friends in the alcohol and drug addiction treatment system, and the labor and
legislative community.
Page 59
MODERN ASSISTANCE PROGRAM
Supports
MOAR and
National Recovery Day
It can save
a save a
life
MOAR Thanks
Modern Assistance
Programs and
Paul McDevitt for
continuous generosity to All!
1400 Hancock Street
Quincy, MA 02169
(617) 774-0331
Page 60
Addiction Affects Everyone
Rick Dyer
Attorney & Advocate for Recovery
rickdyer.org
(617) 965-3637
Recovery is a right–
WE DO RECOVER
Supporting National Recovery Month &
Massachusetts Organization for
Addiction Recovery
“Desperation is a gift and surrender opens the door to
our greatest human potential. It is through the circle
of recovery that we restore the human spirit and
break the cycle of addiction”
-Rick Dyer & Beth Lewinger
Page 61
GAVIN FOUNDATION, INC. www.gavinfoundation.org
Gavin House, Cushing House Boys, Cushing House Girls, Total Immersion Program, AAWOL Program, Graduate Center,
Diversion Program, Ostiguy Recovery High School &
The Speaker for Hope Program
Dedicated to the Restoration of Dignity
Page 62
SuperGroupFEATURING:
ALSO FEATURING:
Right Turn’s 8th Annual Benefit Concert
Evan Dando
Simon KirkeBad Company and Free
James Montgomery
Blues Legend
Barry Goudreauformally of Boston
Shea RoseBoston Music Awards Best Vocalist
Chris TrapperThe Push Stars
Woody GiessmannThe Del Fuegos
David HullThe Joe Perry Project
Marty RichardThe J. Geil’s Band
Sandy MacDonaldThe Commitments
Joan OsborneGrammy Award Winner
Glen David AndrewsFeatured Performer in HBO’s Treme TV Series
G. E. SmithNBC’s Saturday Night Live Band Leader
Trombone ShortyNew Orleans’ Supafunkrocker
Paula ColeGrammy Award Winner
Lemonheads’ Member
Steve SweeneyHosted by Comedy Legend
All Proceeds benefit Right Turn’s Addiction & Mental Health Services
Sunday October 27, 7:00 pmRoyale 279 Tremont Street, Boston
Tickets available on TicketsMaster.comGeneral Admission Tickets $40, VIP Tickets $100. Meet & Greet food provided by Jasper White.
Page 63
Supporting an Alcohol
Advertisement Free Environment
in Massachusetts
We are a group of concerned community members in
Greater Boston; professionals, youth,
parents, and residents who are concerned about the
negative impact of alcohol advertising in
our communities. A national study showed “for each
additional ad a young person saw (above the monthly
average of 23), he or she drank 1% more.
We still have work to do!
Please continue to support SAFE-MA as we work with
Representative Martin Walsh to pass HB 2897,
a bill to prohibit Alcohol Advertising
on Commonwealth Property.
Go to our Facebook Page
SAFE MA to learn more.
The MBTA banned alcohol advertising on the T
effective July 1, 2012.
SAFE-MA thanks you for your support!
Page 64
Fall River • New Bedford • 508.996.3147 • www.sevenhills.org
At Seven Hills Behavioral Health, individuals with life challenges turn oppression into opportunity; adversity into achievement; desperation into dreams; and dreams into reality.
Seven Hills Behavioral Health (SHBH), an Affiliate of Seven Hills Foundation, is CARF-accredited with over 40 years’ experience providing a wide range of bilingual social and human services to the New Bedford, Fall River, Chelmsford, Worcester and Leominster areas.
SHBH brings hope to young people seeking educational opportunity; individuals struggling with substance abuse, coping with an emotional or mental health issue, or suffering from HIV/AIDS; and to families striving to achieve and maintain a balanced, healthy home environment.
At Seven Hills Behavioral Health, we empower the individuals we support to turn all of their life challenges into bright futures that embrace opportunities of a lifetime. Take the first step and call today.
Page 65
WAY OF LIFE “STEPPERS” Recovery Gifts www.wayolife.com
P.O. Box 3087 Fayville, MA 01745
“12 Steppers”
There are 24 pieces in male and female figures.
1 Powerless Recovery Day Special Offer 2 Believing Full 12 Piece set of men or women 12 Steppers 3 Surrender $250.00 4 Inventory 5 Admitting 6 Readiness For a color catalogue sheet of all 24 figurines 7 Humility www.wayolife.com8 Willing Each figurine is approximately 2 inches tall, 9 Amends weighing about 2 ounces. 10 Continuing Figurines are priced at $29.95 each. 11 Meditating Leroy Kelly & Elliot Brown 12 Awakening
Page 66
Proud to Join the Voices for Recovery
Together on Pathways to Wellness
Today and Everyday!
www.nebhealth.org
Celebrating National Recovery Month
2013
Page 67
Massachusetts Public Health Association
Action for a Healthy Massachusetts
101 Tremont St.,
Suite 1011
Boston, MA 02108
Tel: (857) 263-7072
Fax: (857) 263-7068
Massachusetts Public Health Association
Proudly supports MOAR
Promoting Recovery,
Prevention and Treatment
across the Commonwealth
NNCC Drop-In Center: This program integrates HIV prevention and education,
substance abuse prevention, hepatitis c, and primary services to the substance
abusing population. It provides a safe space for individuals who are active or are
in recovery to get information and referrals; health education; peer-led interven-
tions; life skills training; and on-going discussions with individuals who use the
center about their needs and the resources that are available. This program pro-
vides anonymous counseling and testing for HIV.
Contact Phone: 413.733-4053
www.newnorthcc.org
We Proudly support
MOAR and Join the
Voices for Recovery
September 2013
Page 68
SMOC Behavioral Healthcare 300 Howard Street
Framingham, MA 01702
508-879-2250 (Voice)
508-620-2637 (Fax)
www.smoc.org
SMOC SUPPORTS NATIONAL RECOVERY MONTH AND MOAR
SMOC Behavioral Healthcare (SBH) assists individuals and families better understand the negative impact
substance misuse/abuse has on the individual, family or their community. SBH takes a person-centered
approach through clinical assessment, coordinated treatment planning and supportive counseling while
guiding individuals and families towards improved physical and mental wellness.
We recognize that improved wellness happens in unique ways and along different timelines for each
individual and family. Through consistent and regular engagement with a multidisciplinary team of
professional treatment providers, progress is possible. Effective treatment coordination supports the
individual and family’s ability to identify the cause of their symptoms, focus on their strengths in order to
manage their symptoms and develop new skills to help eliminate their symptoms.
Individual Substance Use and Mental Health Counseling
Court Ordered Substance Abuse Evaluation
Operating Under the Influence Programs: Driver Alcohol Education (DAE)
Second Offenders Aftercare (SOA)
Family & Children Services: Outpatient
In-Home Therapy
In-Home Behavioral Services
Substance Use Residential Programs: Serenity House (Single Women)
Rhodes to Recovery (Single Women)
Sage House (Male Head of Households)
Community Support Program
Two Outpatient Clinics: 300 Howard Street 230 Maple Street
Framingham, MA Marlborough, MA
For all Substance Use and Mental Health counseling referrals call: 508-879-2250, Ext 145
For all Operating Under the Influence referrals call: 508-480-0092 Ext. 201
Page 69
Proudly Supports
MOAR
Massachusetts Organization for Addiction Recovery
in joining the
Voices for Recovery–
Together on
Pathways to Wellness.
Utility Workers
Union of America
Local 369
Page 70
Supporting National Recovery
Month and MOAR
Joining the Voices for Recovery
Together on Pathways to Wellness
Welcome to your one-stop source for real estate services covering the Greater Boston and surrounding areas (including Hyde Park, Roslindale, Jamaica Plain, West Roxbury, Milton and Dedham). Real estate is one of the most exciting investments you can make, and it should be a fun and rewarding experience. We're available to help you find everything you will need to buy or sell your home. It's our goal to provide you with superior service at all times, so please tell us more about you!
Tierney Realty Group 9 Fairmount Avenue Hyde Park, MA 02136 Fax: 617-361-6598
www.tierneyrg.com
Page 71
The Western
Massachusetts
Substance Abuse
Providers
Congratulates MOAR on another
successful year of bringing
providers, consumers, and
State Officials together to
further support the
Recovery Movement.
We Proudly Join the Voices for Recovery-
Together on Pathways to Wellness
September 2013
Page 72
Suboxone ®
B e c a u s e Tr e a t m e n t Tr a n s f o r m s L i v e s
Please visit us at suboxone.com or contact us at 1-877-SUBOXONE.
proudly supports the efforts of this organization.
Reckitt Benckiser Pharmaceuticals Inc. maker of
Page 73
Teen Challenge was founded and birthed through prayer and obedience. In 1958, small town Pennsylvania Preacher David Wilkerson was called to New York City to help save a group of teenage gang members. He was not able to reach them specifically, but managed to reach many other gang members in the community. From that Teen Challenged was birthed. The Cross and the Switchblade was the book that set the tone for the testimony’s that where yet to come.
Teen Challenge has been successfully saving people, by the power of Jesus Christ, for the past 51 years. Teen Challenge is now in 81 countries and has over 200 centers throughout the US. Teen Challenge New England has had a significant part in reaching the lost. Teen Challenge New England has 10 centers and is continuing to grow. Teen Challenge Boston has been in the communities for the past 25 yrs. One of the ways TC Boston has reached others in need is by its Choir Ministry. The choir brings song and testimony that captures the message of God’s Saving Grace and Testimonies of the changing power of Jesus Christ. It allows the congregation to invite others that are suffering to hear the “message of the cross” in its truest form…salvation. We ask that you allow your congregation to respond with a love offering for the newly acquired building that you see here on the right. We also request an honorarium of $350 to $500 which will help with the ministerial needs such as Gas, Food, Housing, and additional costs.
We want to come to your church and share the good news. We have open dates throughout the rest of the year. To contact for choir booking call us at (617) 318-1380 or reach via email [email protected]. For additional information visit us at our web site www.tcboston.org
Page 74
Page 75
VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vialIntramuscular
BRIEF SUMMARY See package insert for full prescribing information (rev. October 2010).
WARNING: HEPATOTOXICITYNaltrexone has the capacity to cause hepatocellular injury when given in excessive doses. Naltrexone is contraindicated in acute hepatitis or liver failure, and its use in patients with active liver disease must be carefully considered in light of its hepatotoxic effects. The margin of separation between the apparently safe dose of naltrexone and the dose causing hepatic injury appears to be only five-fold or less. VIVITROL does not appear to be a hepatotoxin at the recommended doses. Patients should be warned of the risk of hepatic injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of VIVITROL should be discontinued in the event of symptoms and/or signs of acute hepatitis [See Warnings and Precautions].
INDICATIONS AND USAGE: VIVITROL is an opioid antagonist. VIVITROL should be part of a comprehensive management program that includes psychosocial support. Opioid-dependent patients, including those being treated for alcohol dependence, must be opioid-free at the time of initial VIVITROL administration. VIVITROL is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration. In addition, VIVITROL is indicated for the prevention of relapse to opioid dependence, following opioid detoxification.
CONTRAINDICATIONS: VIVITROL is contraindicated in: patients with acute hepatitis or liver failure, patients receiving opioid analgesics, patients with current physiologic opioid dependence, patients in acute opioid withdrawal, any individual who has failed the naloxone challenge test or has a positive urine screen for opioids, and patients who have previously exhibited hypersensitivity to naltrexone, polylactide-co-glycolide (PLG), carboxymethylcellulose, or any other components of the diluent.
WARNINGS AND PRECAUTIONS: Injection Site Reactions: VIVITROL injections may be followed by pain, tenderness, induration, swelling, erythema, bruising, or pruritus; however, in some cases injection site reactions may be very severe. In the clinical trials, one patient developed an area of induration that continued to enlarge after 4 weeks, with subsequent development of necrotic tissue that required surgical excision. In the postmarketing period, additional cases of injection site reaction with features including induration, cellulitis, hematoma, abscess, sterile abscess, and necrosis, have been reported. Some cases required surgical intervention, including debridement of necrotic tissue. Some cases resulted in significant scarring. The reported cases occurred primarily in female patients. VIVITROL is administered as an intramuscular gluteal injection, and inadvertent subcutaneous injection of VIVITROL may increase the likelihood of severe injection site reactions. The needles provided in the carton are customized needles. VIVITROL must not be injected using any other needle. The needle lengths (either 1.5 inches or 2 inches) may not be adequate in every patient because of body habitus. Body habitus should be assessed prior to each injection for each patient to assure that the proper needle is selected and that the needle length is adequate for intramuscular administration. Healthcare professionals should ensure that the VIVITROL injection is given correctly, and should consider alternate treatment for those patients whose body habitus precludes an intramuscular gluteal injection with one of the provided needles. Patients should be informed that any concerning injection site reactions should be brought to the attention of the healthcare professional. Patients exhibiting signs of abscess, cellulitis, necrosis, or extensive swelling should be evaluated by a physician to determine if referral to a surgeon is warranted. Eosinophilic Pneumonia: In clinical trials with VIVITROL, there was one diagnosed case and one suspected case of eosinophilic pneumonia. Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. Similar cases have been reported in postmarketing use. Should a person receiving VIVITROL develop progressive dyspnea and hypoxemia, the diagnosis of eosinophilic pneumonia should be considered. Patients should be warned of the risk of eosinophilic pneumonia, and advised to seek medical attention should they develop symptoms of pneumonia. Clinicians should consider the possibility of eosinophilic pneumonia in patients who do not respond to antibiotics. Hypersensitivity Reactions Including Anaphylaxis: Cases of urticaria, angioedema, and anaphylaxis have been observed with use of VIVITROL in the clinical trial setting and in postmarketing use. Patients should be warned of the risk of hypersensitivity reactions, including anaphylaxis. In the event of a hypersensitivity reaction, patients should be advised to seek immediate medical attention in a healthcare setting prepared to treat anaphylaxis. The patient should not receive any further treatment with VIVITROL.
Unintended Precipitation of Opioid Withdrawal: To prevent occurrence of an acute abstinence syndrome (withdrawal) in patients dependent on opioids, or exacerbation of a pre-existing subclinical abstinence syndrome, opioid-dependent patients, including those being treated for alcohol dependence, must be opioid-free for a minimum of 7-10 days before starting VIVITROL treatment. Since the absence of an opioid drug in the urine is often not sufficient proof that a patient is opioid-free, a naloxone challenge test should be employed if the prescribing physician feels there is a risk of precipitating a withdrawal reaction following administration of VIVITROL. Patients treated for alcohol dependence with VIVITROL should be assessed for underlying opioid dependence and for any recent use of opioids prior to initiation of treatment with VIVITROL. Precipitated opioid withdrawal has been observed in alcohol-dependent patients in circumstances where the prescriber had been unaware of the additional use of opioids or dependence on opioids. Opioid Overdose at the End of Dosing Interval, After Missing a Dose and Following an Attempt to Overcome Opioid Blockade: After opioid detoxification, patients are likely to have reduced tolerance to opioids. Although VIVITROL blocks the effects of exogenous opioids for 28 days after administration, cases of opioid overdose with fatal outcomes have been reported in patients who used opioids at the end of a dosing interval or when missing a dose. Patients who have been treated with VIVITROL may respond to lower doses of opioids than previously used. This could result in potentially life-threatening opioid intoxication (respiratory compromise or arrest, circulatory collapse, etc.). Patients should be aware that they may be more sensitive to lower doses of opioids after VIVITROL treatment is discontinued. Reduced tolerance is especially of concern at the end of a dosing interval, that is, near the end of the month after VIVITROL was administered, or after a dose of VIVITROL is missed. It is important that patients inform family members and the people closest to the patient of this increased sensitivity to opioids and the risk of overdose. There is also the possibility that a patient who is treated with VIVITROL could overcome the opioid blockade effect of VIVITROL. Although VIVITROL is a potent antagonist with a prolonged pharmacological effect, the blockade produced by VIVITROL is surmountable. This poses a potential risk to individuals who attempt, on their own, to overcome the blockade by administering large amounts of exogenous opioids. Any attempt by a patient to overcome the antagonism by taking opioids is very dangerous and may lead to fatal overdose. Injury may arise because the plasma concentration of exogenous opioids attained immediately following their acute administration may be sufficient to overcome the competitive receptor blockade. As a consequence, the patient may be in immediate danger of suffering life-endangering opioid intoxication (e.g., respiratory arrest, circulatory collapse). Patients should be told of the serious consequences of trying to overcome the opioid blockade. Depression and Suicidality: Alcohol- and opioid-dependent patients, including those taking VIVITROL, should be monitored for the development of depression or suicidal thinking. Families and caregivers of patients being treated with VIVITROL should be alerted to the need to monitor patients for the emergence of symptoms of depression or suicidality, and to report such symptoms to the patient’s healthcare professional. Alcohol Dependence: In controlled clinical trials of VIVITROL administered to adults with alcohol dependence, adverse events of a suicidal nature (suicidal ideation, suicide attempts, completed suicides) were infrequent overall, but were more common in patients treated with VIVITROL than in patients treated with placebo (1% vs. 0). In some cases, the suicidal thoughts or behavior occurred after study discontinuation, but were in the context of an episode of depression which began while the patient was on study drug. Two completed suicides occurred, both involving patients treated with VIVITROL. Depression-related events associated with premature discontinuation of study drug were also more common in patients treated with VIVITROL (~1%) than in placebo-treated patients (0). In the 24-week, placebo-controlled pivotal trial in 624 alcohol-dependent patients, adverse events involving depressed mood were reported by 10% of patients treated with VIVITROL 380 mg, as compared to 5% of patients treated with placebo injections. Opioid Dependence: In an open-label, long-term safety study conducted in the US, adverse events of a suicidal nature (depressed mood, suicidal ideation, suicide attempt) were reported by 5% of opioid-dependent subjects treated with VIVITROL 380 mg (n=101) and 10% of opioid-dependent subjects treated with oral naltrexone (n=20). In the 24-week, placebo-controlled pivotal trial that was conducted in Russia in 250 opioid-dependent patients, adverse events involving depressed mood or suicidal thinking were not reported by any patient in either treatment group (VIVITROL 380 mg or placebo). Intramuscular Injections: As with any intramuscular injection, VIVITROL should be administered with caution to patients with thrombocytopenia or any coagulation disorder (e.g., hemophilia and severe hepatic failure). When Reversal of VIVITROL Blockade is Required for Pain Management: In an emergency situation in patients receiving VIVITROL, suggestions for pain management include regional analgesia or use of non-opioid analgesics. If opioid therapy is required as part of anesthesia or analgesia, patients should be continuously monitored in an anesthesia care setting, by persons not involved in the conduct of the surgical or diagnostic procedure. The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs
Page 76
and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. Irrespective of the drug chosen to reverse VIVITROL blockade, the patient should be monitored closely by appropriately trained personnel in a setting equipped and staffed for cardiopulmonary resuscitation. Alcohol Withdrawal: Use of VIVITROL does not eliminate nor diminish alcohol withdrawal symptoms. Interference with Laboratory Tests: VIVITROL may be cross-reactive with certain immunoassay methods for the detection of drugs of abuse (specifically opioids) in urine. For further information, reference to the specific immunoassay instructions is recommended.
ADVERSE REACTIONS: Clinical Studies Experience: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In all controlled and uncontrolled trials during the premarketing development of VIVITROL, more than 1100 patients with alcohol and/or opioid dependence have been treated with VIVITROL. Approximately 700 patients have been treated for 6 months or more, and more than 400 for 1 year or longer. Adverse Events Leading to Discontinuation of Treatment: Alcohol Dependence: In controlled trials of 6 months or less in alcohol-dependent patients, 9% of alcohol-dependent patients treated with VIVITROL discontinued treatment due to an adverse event, as compared to 7% of the alcohol-dependent patients treated with placebo. Adverse events in the VIVITROL 380 mg group that led to more dropouts than in the placebo-treated group were injection site reactions (3%), nausea (2%), pregnancy (1%), headache (1%), and suicide-related events (0.3%). In the placebo group, 1% of patients withdrew due to injection site reactions, and 0% of patients withdrew due to the other adverse events. Opioid Dependence: In a controlled trial of 6 months, 2% of opioid-dependent patients treated with VIVITROL discontinued treatment due to an adverse event, as compared to 2% of the opioid-dependent patients treated with placebo.
Common Adverse Reactions: Alcohol Dependence:
Table 1: Treatment-emergent Adverse Reactions (Reactions in ≥ 5% of patients with alcohol dependence treated with VIVITROL and occurring more frequently in the combined VIVITROL group than in the placebo group).
a) Includes the preferred terms: diarrhea NOS; frequent bowel movements; gastrointestinal upset; loose stools
b) Includes the preferred terms: abdominal pain NOS; abdominal pain upper; stomach discomfort; abdominal pain lower
c) Includes the preferred terms: nasopharyngitis; pharyngitis streptococcal; pharyngitis NOSd) Includes the preferred terms: anxiety NEC; anxiety aggravated; agitation; obsessive
compulsive disorder; panic attack; nervousness; post-traumatic stresse) Includes the preferred terms: malaise; fatigue (these two comprise the majority of
cases); lethargy; sluggishnessf ) Includes the preferred terms: muscle cramps; spasms; tightness; twitching; stiffness; rigidityg) Includes the preferred terms: rash NOS; rash papular; heat rashh) Includes the preferred terms: headache NOS; sinus headache; migraine; frequent headaches
Common Adverse Reactions: Opioid Dependence
In the open-label, long-term safety study conducted in the US, the commonly-reported adverse reactions among the opioid-dependent patients in the study were similar to those commonly observed events in the alcohol-dependent populations in VIVITROL clinical trials as displayed in Table 1, above. For example, injection site reactions of all types, nausea and diarrhea occurred in more than 5% of patients on VIVITROL in the open-label study. In contrast, 48% of the opioid-dependent patients had at least one adverse event in the “Infections and Infestations” Body System. Adverse Reactions/Preferred Terms of nasopharyngitis, upper respiratory tract infection, urinary tract infection, and sinusitis were most commonly reported.
In the placebo-controlled study in opioid-dependent patients conducted in Russia, the overall frequency of adverse events was lower than in the US population described above. Table 2 lists treatment-emergent clinical adverse events, regardless of causality, occurring in ≥2% of patients with opioid dependence, for which the incidence was greater in the VIVITROL group than in the placebo group. All adverse events were assessed as having a maximum intensity of “mild” or “moderate”.
Table 2: Treatment-emergent Clinical Adverse Events (Events in ≥ 2% of patients with opioid dependence treated with VIVITROL and occurring more frequently in the VIVITROL group than in the placebo group).
Musculoskeletal & Connective Tissue Disorders
Arthralgia, arthritis, joint stiffness
11 5 1 4 24 12 12 6 37 9
Back pain, back stiffness
10 5 1 4 12 6 14 7 27 6
Muscle cramps f)
3 1 0 0 16 8 5 2 21 5
Skin & Subcutaneous Tissue Disorders
Rash g) 8 4 3 12 12 6 10 5 25 6
Nervous System Disorders
Headache h) 39 18 9 36 51 25 34 16 94 21
Dizziness syncope
9 4 4 16 27 13 27 13 58 13
Somnolence, sedation
2 1 3 12 8 4 9 4 20 5
Metabolism & Nutrition Disorders
Anorexia, appetite decreased NOS, appetite disorder NOS
6 3 5 20 30 14 13 6 48 11
Body System Adverse Reaction/Preferred Term
Placebo Naltrexone for extended-release injectable suspension
N=214 400 mg N=25
380 mg N=205
190 mg N=210
All N=440
N % N % N % N % N %
Gastrointestinal Disorders
Nausea 24 11 8 32 68 33 53 25 129 29
Vomiting NOS 12 6 3 12 28 14 22 10 53 12
Diarrhea a) 21 10 3 12 27 13 27 13 57 13
Abdominal pain b) 17 8 4 16 23 11 23 11 50 11
Dry mouth 9 4 6 24 10 5 8 4 24 5
Infections & Infestations
Pharyngitis c) 23 11 0 0 22 11 35 17 57 13
Psychiatric Disorders
Insomnia, sleep disorder
25 12 2 8 29 14 27 13 58 13
Anxiety d) 17 8 2 8 24 12 16 8 42 10
Depression 9 4 0 0 17 8 7 3 24 5
General Disorders & Administration Site Conditions
Any ISR 106 50 22 88 142 69 121 58 285 65
Injection site tenderness
83 39 18 72 92 45 89 42 199 45
Injection site induration
18 8 7 28 71 35 52 25 130 30
Injection site pain 16 7 0 0 34 17 22 10 56 13
Other ISR (primarily nodules, swelling)
8 4 8 32 30 15 16 8 54 12
Injection site pruritus
0 0 0 0 21 10 13 6 34 8
Injection site ecchymosis
11 5 0 0 14 7 9 4 23 5
Asthenic conditions e)
26 12 3 12 47 23 40 19 90 20
Body System Adverse Event/ Preferred Term
Placebo N=124
VIVITROL 380 mg N=126
n % n %
Investigations Alanine aminotransferase increased
7 6 16 13
Aspartate aminotransferase increased
3 2 13 10
Gamma- glutamyltransferase increased
4 3 9 7
Infections & Infestations Nasopharyngitis 3 2 9 7
Influenza 5 4 6 5
Psychiatric Disorders Insomnia 1 1 8 6
Page 77
Alkermes® and VIVITROL® are registered trademarks of Alkermes, Inc.Manufactured and marketed by Alkermes, Inc.©2010 Alkermes, Inc. VIV 107G December 2010 Printed in U.S.A. All rights reserved.
Laboratory Tests: Eosinophil Count: In clinical trials, subjects on VIVITROL had increases in eosinophil counts relative to subjects on placebo. With continued use of VIVITROL, eosinophil counts returned to normal over a period of several months. Platelet Count: VIVITROL 380 mg was associated with a decrease in platelet count. In clinical trials, alcohol-dependent patients treated with VIVITROL experienced a mean maximal decrease in platelet count of 17.8 x 103/μL, compared to 2.6 x 103/μL in placebo patients. After 24 weeks of treatment, opioid-dependent patients treated with VIVITROL experienced a mean maximal decrease in platelet count of 62.8 x 103/μL, compared to 39.9 x 103/μL in placebo patients. In randomized controlled trials, VIVITROL was not associated with an increase in bleeding-related adverse events. Hepatic Enzyme Elevations: In short-term, controlled trials, in alcohol-dependent patients, the incidence of AST elevations associated with VIVITROL treatment was similar to that observed with oral naltrexone treatment (1.5% each) and slightly higher than observed with placebo treatment (0.9%). In the 6-month controlled trial conducted in opioid-dependent subjects, 89% had a baseline diagnosis of hepatitis C infection, and 41% had a baseline diagnosis of HIV infection. There were frequently observed elevated liver enzyme levels (ALT, AST, and GGT); these were more commonly reported as adverse events in the VIVITROL 380 mg group than in the placebo group. Patients could not enroll in this trial if they had a baseline ALT or AST value that was more than three times the upper limit of normal. More patients treated with VIVITROL in this study experienced treatment-emergent elevations in transaminases to more than three times the upper limit of normal than patients treated with placebo. Shifts to more than three times the upper limit of normal occurred in 20% of patients treated with VIVITROL as compared with 13% of placebo patients. Shifts in values of AST to more than three times the upper limit were also more common in the VIVITROL (14%) arm compared with the placebo (11%) arm. Opioid-dependent patients treated with VIVITROL experienced a mean maximal increase from baseline ALT levels of 61 IU/L compared with 48 IU/L in placebo patients. Similarly for AST, opioid-dependent patients treated with VIVITROL experienced a mean maximal increase from baseline AST levels of 40 IU/L compared with 31 IU/L in placebo patients. Creatinine Phosphokinase: In short-term controlled trials in alcohol-dependent patients, more patients treated with VIVITROL 380 mg (11%) and oral naltrexone (17%) shifted from normal creatinine phosphokinase (CPK) levels before treatment to abnormal CPK levels at the end of the trials, compared to placebo patients (8%). In open-label trials, 16% of patients dosed for more than 6 months had increases in CPK. For both the oral naltrexone and VIVITROL 380 mg groups, CPK abnormalities were most frequently in the range of 1–2 x ULN. However, there were reports of CPK abnormalities as high as 4 x ULN for the oral naltrexone group, and 35 x ULN for the VIVITROL 380 mg group. Overall, there were no differences between the placebo and naltrexone (oral or injectable) groups with respect to the proportions of patients with a CPK value at least three times the upper limit of normal. No factors other than naltrexone exposure were associated with the CPK elevations. More opioid-dependent patients treated with VIVITROL 380 mg (39%) shifted from normal CPK levels before treatment to abnormal CPK levels during the study as compared to patients treated with placebo (32%). There were reports of CPK abnormalities as high as 41.8 x ULN for the placebo group, and 22.1 x ULN for the VIVITROL 380 mg group.
USE IN SPECIFIC POPULATIONS:
Pregnancy: There are no adequate and well-controlled studies of either naltrexone or VIVITROL in pregnant women. VIVITROL should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Pregnancy Category C: Reproduction and developmental studies have not been conducted for VIVITROL. Studies with naltrexone administered via the oral route have been conducted in pregnant rats and rabbits. Teratogenic Effects: Naltrexone has been shown to increase the incidence of early fetal loss when given to rats at doses ≥ 30 mg/kg/day (11-times the human exposure based on an AUC(0-28d) comparison) and to rabbits at oral doses ≥ 60 mg/kg/day (2-times the human exposure based on an AUC(0-28d) comparison). There was no evidence of teratogenicity when naltrexone was administered orally to rats and rabbits during the period of major organogenesis at doses up to 200 mg/kg/day (175- and 14-times the human exposure based on an AUC(0-28d) comparison, respectively).
Labor and Delivery: The potential effect of VIVITROL on duration of labor and delivery in humans is unknown. Nursing Mothers: Transfer of naltrexone and 6ß-naltrexol into human milk has been reported with oral naltrexone. Because of the potential for tumorigenicity shown for naltrexone in animal studies, and because of the potential for serious adverse reactions in nursing infants from VIVITROL, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use: The safety and efficacy of VIVITROL have not been established in the pediatric population. The pharmacokinetics of VIVITROL have not been evaluated in a pediatric population. Geriatric Use: In trials of alcohol-dependent subjects, 2.6% (n=26) of subjects were >65 years of age, and one patient was >75 years of age. Clinical studies of VIVITROL did not include sufficient numbers of subjects age 65 and over to determine whether they respond differently from younger subjects. No subjects over age 65 were included in studies of opioid-dependent subjects. The pharmacokinetics of VIVITROL have not been evaluated in the geriatric population. Renal Impairment: Pharmacokinetics of VIVITROL are not altered in subjects with mild renal insufficiency (creatinine clearance of 50-80 mL/min). Dose adjustment is not required in patients with mild renal impairment. VIVITROL pharmacokinetics have not been evaluated in subjects with moderate and severe renal insufficiency. Because naltrexone and its primary metabolite are excreted primarily in the urine, caution is recommended in administering VIVITROL to patients with moderate to severe renal impairment. Hepatic Impairment: The pharmacokinetics of VIVITROL are not altered in subjects with mild to moderate hepatic impairment (Groups A and B of the Child-Pugh classification). Dose adjustment is not required in subjects with mild or moderate hepatic impairment. VIVITROL pharmacokinetics were not evaluated in subjects with severe hepatic impairment.
Drug Interactions: Patients taking VIVITROL may not benefit from opioid-containing medicines. Naltrexone antagonizes the effects of opioid-containing medicines, such as cough and cold remedies, antidiarrheal preparations and opioid analgesics.
OVERDOSAGE: There is limited experience with overdose of VIVITROL. Single doses up to 784 mg were administered to 5 healthy subjects. There were no serious or severe adverse events. The most common effects were injection site reactions, nausea, abdominal pain, somnolence, and dizziness. There were no significant increases in hepatic enzymes. In the event of an overdose, appropriate supportive treatment should be initiated.
This brief summary is based on VIVITROL Full Prescribing Information (rev. October 2010).
Vascular Disorders Hypertension 4 3 6 5
General Disorders and Administration Site Conditions
Injection site pain 1 1 6 5
Gastrointestinal Disorders Toothache 2 2 5 4
Nervous System Disorders Headache 3 2 4 3
Page 78
Organization Page Organization2 Page
Adcare Educational Institute 20 MAADAC, MA Assoc. of Alcoholism & Drug Abuse Counselors 55
Adcare Hospital Back MBAAC, Massachusetts Black Alcoholism & Addiction Council 25
Advocates Inc. 7 MBHP, Massachusetts Behavioral Health Partnership 82
Alkermes 3 MBSACC, Massachusetts Board of Substance Abuse Counselor Certification 45
Allston Brighton Substance Abuse Task Force 15 MHSA, Middlesex Human Service Agency 46
AREAS- Addiction Recovery Education Access to Services 34 Middlesex Recovery, PC 58
ASAM American Society of Addiction Medicine 45 Modern Assistance Program 60
ASAP Environmental 47 MPHA, MA Public Health Association 68
Association for Behavioral Healthcare 10 New England Center 43
ATCNE, Addiction Treatment Center of New England, Inc. 52 New North Citizen Council 68
Bay Cove Human Services Inc. 56 North Suffolk Mental Health Association 6
Behavioral Health Network 30 Phoenix Houses of NE 80
Boston ASAP, Alcohol and Substance Abuse Program, Inc. 31 Physician Health Services 23
Bureau of Substance Abuse Services 5 Pine Street Inn 27
Caron 29 Public Policymaker Access Guide 16
Casa Esperanza 18 Reckitt Benckiser 73
CASA, Community Association Serving Alcoholics 28 Recovery Homes Collaborate 59
Casey Washburn Memorial Fund 17 Representative Elizabeth Malia 51
COASA 21 Rev.Michael Scarlett 54
Comics for Recovery 22 Revere Cares 31
Commonwealth Mental Health & Wellness Center 25 Richard Dyer 61
Dimock Center 2 Right Turn 63
EAPA- Employee Assistance Program Association 24 Ruth and Ray Kelley 47
Edwina Martin House 39 SAAFE-Supporting an Alcohol Ad Free Environment 64
Faulkner Hospital/ Addctn Rec. Program 35 Self Esteem Boston 27
Foundation for Alcohol Education 37 Seven Hill Behavioral Health 65
Gavin Foundation Inc. 62 SMOC, South Middlesex Opportunity Council 69
Gosnold 38 South Boston Hope and Recovery Coalition/Collaborative Center 44
Granada House 40 Spectrum Health Systems, Inc. 1, 81
Health Resources in Action 32 Teen Challenge New England Inc. 74
High Point Treatment Center 41, 42 The Icecream Smith 47
Hope House, Inc. 48 The Transformation Center 26
Improbable Players 43 Tierney Realty Group 71
Institute for Health and Recovery 33 Trudy Avery 39
Joe Kelleher 31 U.W.U.A. Local 369 70
Lahey Behavioral Health 67 Victory Programs 57
LAP, Labor Assistance Professionals 49 Vivitrol 75
Lemuel Shattuck Hospital 50 Way of Life 66
Lowell House Inc. 54 Western Mass Substance Abuse Providers 72
MA Council on Compulsive Gambling 12
MA Int. Nurses Society on Addictions 53
MA Substance Abuse Information and Education Helpline 32
INDEX
Page 79
Phoenix House is leading
individuals, families, and communities
from disrupted to productive lives.
Phoenix House Springfield Center Phoenix House Academy Phoenix House
Adult Residential Treatment Adolescent Residential Outpatient Services
240-242 Central Street 15 Mulberry Street 15 Mulberry Street
Springfield, MA 01105 Springfield, MA 01105 Springfield, MA 01105
413 746 1207 413 739 2440 413 739 2440, Ext. 6259
Phoenix House at Hampden County Arbor House Program
Community Corrections Centers Transitional Support Services
311 State Street 130 Pine Street
Springfield, MA 01105 Holyoke, MA 01040
413 733 5469 413 538 8188
1 800 DRUG HELP www.phoenixhouse.org
PHOENIX HOUSE WESTERN
MASSACHUSETTS
A PROUD PARTNER OF THE
MASSACHUSETTS ORGANIZATION FOR
ADDICTION RECOVERY
Page 80
Page 81
The Massachusetts
Behavioral Health
Partnership
(MBHP) is proud to
support MOAR and
the 2013 National
Alcoholism and
Drug Recovery
Month celebration
“Joining the Voices
for Recovery.”
Massachusetts Behavioral
Health Partnership
1000 Washington Street, Suite 310
Boston, MA 02118-5002
1-800-495-0086
www.masspartnership.com
Page 81Page 81
The New England Center for Alcohol & Drug Care
ADCARE….Help For All Generations
Dependency on drugs and alcohol can afflict anyone…
AdCare Hospital knows that chemical dependency can be brought on by many factors. Our professional staff is dedicated to the treatment of alcohol and
drug dependency and to prevention through community education.
Inpatient Treatment
Admission 1-800-ALCOHOL (252-6465) &
Referrals 1-800-345-3552
Outpatient Treatment Boston, MA 617-227-2622 Quincy, MA 617-328-0639 Worcester, MA 508-799-9000 N. Dartmouth, MA 508-999-1102 W. Springfield, MA 413-209-3124 Warwick, RI 401-732-1500
www.adcare.com
September is National Recovery Month.
AdCare Hospital is proud to be part of the voices and faces for recovery.